5.2 Organogenesis: Cardiovascular and Respiratory System Development

5.2 Organogenesis: Cardiovascular and Respiratory System Development

The cardiovascular system is the first organ system to reach functional capacity in the human embryo, beginning coordinated contractions by day 21 to 22. Respiratory development proceeds concurrently through distinct histological stages, preparing the fetus for the rapid transition to aerial respiration at birth.

---

Cardiovascular Embryology

Heart Tube Looping and Left-Right Asymmetry

During week 4, the linear primary heart tube undergoes dextral (rightward) looping to position the primitive atrium dorsally and the primitive ventricle ventrally. This directional bending relies on cilia-driven asymmetrical signaling of Nodal and Lefty genes.

Clinical Connection: Defective ciliary dynein motors disrupt left-right body axis specification. This causes Kartagener syndrome (primary ciliary dyskinesia), characterized by situs inversus (heart and organs inverted), chronic sinusitis, bronchiectasis, and male infertility due to immotile sperm flagella.

Atrial Septation

Partitioning of the common atrium involves a synchronized sequence of septum growth and programmed cell death:

Septum Primum grows down toward Cushion → Ostium Primum narrows
  → Apoptosis forms Ostium Secundum → Septum Secundum grows alongside
  → Foramen Ovale acts as one-way valve (Right-to-Left Shunt)

1. Septum Primum grows from the roof of the common atrium toward the endocardial cushions, leaving an opening called the ostium primum.
2. Before the ostium primum fully closes, apoptosis creates perforations in the upper septum primum that coalesce into the ostium secundum.
3. Septum Secundum develops to the right of the septum primum. It covers the ostium secundum but leaves a crescentic lower opening: the foramen ovale.
4. The remaining flexible lower portion of septum primum acts as a one-way valve, allowing oxygenated blood to flow from right to left atrium during fetal life.

Ventricular Septation and VSD

Ventricular septation requires dual tissue participation:

• Muscular Ventricular Septum: Grows superiorly from the floor of the primitive ventricle.
• Membranous Ventricular Septum: Formed by the fusion of the neural crest-derived aorticopulmonary septum with the endocardial cushions and muscular septum.

A membranous Ventricular Septal Defect (VSD) is the single most common congenital cardiac anomaly. Incomplete fusion of these components leads to left-to-right shunting postnatally, causing pulmonary hypertension and eventual Eisenmenger syndrome if unrepaired.

Aortic Arch Derivatives

The pharyngeal arch arteries undergo extensive remodeling between weeks 4 and 8 to form the major arterial pathways:

---

Fetal Circulation and Postnatal Remnants

Fetal circulation is designed to divert oxygenated placental blood away from unventilated fetal lungs and non-functional GI tract directly toward the brain and systemic organs.

Placenta → Umbilical Vein → Ductus Venosus (bypasses liver) → IVC → Right Atrium
  ├─→ Foramen Ovale → Left Atrium → Left Ventricle → Systemic Circulation (Brain)
  └─→ Right Ventricle → Pulmonary Trunk → Ductus Arteriosus → Descending Aorta

Postnatal Circulatory Changes

At birth, lung inflation decreases pulmonary vascular resistance, while clamping the umbilical cord increases systemic vascular resistance. This pressure shift reverses atrial gradients, snapping the septum primum against septum secundum to close the foramen ovale functionally.

Pharmacological Control: Indomethacin (an NSAID) inhibits prostaglandin synthesis and promotes closure of a Patent Ductus Arteriosus (PDA). Conversely, Prostaglandin E1 (alprostadil) keeps the ductus arteriosus open in ductal-dependent cyanotic heart lesions (e.g., transposition of great arteries).

---

Respiratory Embryology

The respiratory system begins at week 4 as the respiratory diverticulum (lung bud), an outgrowth of the ventral wall of the foregut endoderm.

Five Stages of Lung Maturation

Pseudoglandular (Wk 5-16) → Canalicular (Wk 16-26) → Saccular (Wk 26-Birth) → Alveolar (8 Mo - 8 Yrs)

1. Embryonic Period (Weeks 4–7): Lung bud develops, bifurcates into lobar bronchi buds, and forms segmentations.
2. Pseudoglandular Period (Weeks 5–16): Branching down to terminal bronchioles occurs. Respiration is impossible; fetus cannot survive.
3. Canalicular Period (Weeks 16–26): Respiratory bronchioles and alveolar ducts form. Capillary network expands. Type II pneumocytes differentiate and begin producing surfactant around week 26. Respiration becomes possible at the end of this phase with intensive care.
4. Saccular / Terminal Sac Period (Week 26 to Birth): Terminal sacs (primitive alveoli) develop and thin out. Capillaries establish close contact with the alveolar basement membrane.
5. Alveolar Period (8 Months Gestation to 8 Years): Mature alveoli multiply rapidly. Approximately 90% of mature alveoli develop postnatally.

Neonatal Respiratory Distress Syndrome (NRDS)

NRDS (hyaline membrane disease) is caused by a structural deficiency of surfactant, primarily dipalmitoylphosphatidylcholine (lecithin), secreted by Type II pneumocytes.

• Surfactant Kinetics: Surfactant reduces alveolar surface tension, preventing atelectasis at end-expiration. Production ramps up significantly after week 32, reaching mature protective levels around week 35 (demonstrated by a lecithin-to-sphingomyelin ratio L/S ratio $\ge$ 2.0 in amniotic fluid).
• Risk Factors: Prematurity, maternal diabetes (fetal hyperinsulinemia inhibits cortisol-mediated surfactant synthesis), and cesarean delivery without labor.
• Pathophysiology: High surface tension causes alveolar collapse, hypoxia, endothelial damage, and fibrin accumulation (forming hyaline membranes).
• Treatment: Antenatal corticosteroids (betamethasone) administered to mother to stimulate surfactant production; postnatal administration of exogenous surfactant and CPAP.